Last update 01 Nov 2024
Cinfa Biotech SL

Cinfa Biotech SL

Subsidiary Company|
2013|
Spain
|
www.cinfabiotech.com

Overview

Related

1
Drugs associated with Cinfa Biotech SL
Pegfilgrastim biosimilar (Cinfa Biotech SL)
Target
CSF-3R
Mechanism
CSF-3R agonists
Active Org.
Mundipharma International Ltd.Mundipharma International Ltd.
Originator Org.
Cinfa Biotech SLCinfa Biotech SL
Active Indication
Febrile Neutropenia [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date20 Nov 2018
2
Clinical Trials associated with Cinfa Biotech SL
NCT02912377 / CompletedPhase 1
Multiple-doses, Randomised, Double-blind, Three-periods, Two-sequences Crossover Study to Assess the Immunogenicity and Pharmacodynamic Comparability of a Biosimilar Pegfilgrastim (B12019) and the Reference Product Neulasta® in Healthy Subjects
NCT02629562 / CompletedPhase 1
Single-dose, Randomised, Double-blind, Two-stage, Two-way Crossover Pharmacokinetic and Pharmacodynamic Evaluation of a Biosimilar Pegfilgrastim (B12019) Versus the Reference Product Neulasta® in Healthy Subjects
100 Clinical Results associated with Cinfa Biotech SL
Login to view more data
0 Patents (Medical) associated with Cinfa Biotech SL
Login to view more data
100 Deals associated with Cinfa Biotech SL
Login to view more data
100 Translational Medicine associated with Cinfa Biotech SL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pegfilgrastim biosimilar (Cinfa Biotech SL)
 ( CSF-3R )		-
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free